Eye injection showdown: which drug restores vision better in diabetes patients?
Symptom relief
ENROLLING_BY_INVITATION
This study compares two common eye injection drugs, aflibercept and bevacizumab, in adults aged 30-60 with diabetic macular edema (fluid buildup in the retina causing vision loss). About 116 participants will receive monthly injections for two months. The goal is to see which dru…
Phase: NA • Sponsor: CMH Multan Institute of Medical Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC